These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6376067)

  • 1. [Target symptoms in the utilization of antidepressants].
    Tatarelli R; Girardi P; Vella G
    Encephale; 1984; 10(1):29-32. PubMed ID: 6376067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI; McFall JP
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 9. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
    BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD
    Psychopharmacol Bull; 1996; 32(4):659-65. PubMed ID: 8993088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy issues with antidepressants.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1997; 58 Suppl 6():32-9. PubMed ID: 9227671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
    Davidson J; Miller R; Van Wyck Fleet J; Strickland R; Manberg P; Allen S; Parrott R
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
    Binz U; Wendt G
    Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074
    [No Abstract]   [Full Text] [Related]  

  • 16. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 18. Open-label non-randomized versus double-blind randomized antidepressive treatment: what are the advantages of clinical decision over randomization?
    Deuschle M; Krumm B; Bindeballe N; Colla M; Hamann B; Lederbogen F; Gilles M; Heuser I
    Pharmacopsychiatry; 2004 Nov; 37(6):299-302. PubMed ID: 15551197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.
    Bares M; Brunovsky M; Kopecek M; Stopkova P; Novak T; Kozeny J; Höschl C
    J Psychiatr Res; 2007; 41(3-4):319-25. PubMed ID: 16889798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile of the novel antidepressant bupropion.
    Stern WC; Harto-Truax N; Rogers J; Miller L
    Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.